000028Sinopharm AccordSZSE

China National Accord Medicines Corporation Ltd.

国药一致

000028

Shenzhen Stock Exchange

BoardMain Board of Shenzhen Stock Exchange
IndustryWholesale
ISINCNE0000009N6
ListedAugust 9, 1993
Websitewww.szaccord.com.cn
IR Emailgyyz0028@sinopharm.com
Phone(+86)755-25875140
Sourcecninfo.com.cn
AddressAccord Pharmaceutical Building, No.15, Bagua 4th Road, Futian District, Shenzhen, Guangdong

Company Overview

China National Accord Medicines Corporation Ltd. is a prominent player in the wholesale and retail sector, primarily engaged in pharmaceutical distribution and retail pharmacy operations. Established in 1993 and listed on the Shenzhen Stock Exchange, the company focuses on serving the Guangdong–Guangxi region while also maintaining a nationwide retail pharmacy network through its subsidiary, Guo Da Drugstore. The company is dedicated to providing comprehensive healthcare solutions and services to medical institutions and consumers alike. The company's core business lines include pharmaceutical distribution, which involves securing supplies of pharmaceuticals and medical devices for various healthcare institutions, and a retail pharmacy network that offers a wide range of health-related products and services. Guo Da Drugstore operates a centralized procurement system and a vast network of stores across 18 provinces, providing prescription and over-the-counter drugs, traditional Chinese medicine, and health management programs. Additionally, the company holds equity stakes in selected pharmaceutical manufacturers, enhancing its market position and capabilities in the healthcare sector.

AI-generated from company disclosures and CNInfo data.

Company Profile

The distribution business of Sinopharm Accord aims to become the leading provider for pharmaceutical distribution and supply chain service in southern China. Distribution of the Company provide comprehensive distribution, logistics and other value-added services for the manufacturers and suppliers of the domestic and foreign medicines, medical apparatus and instruments, consumables, other health care products, downstream hospitals, other distributors, retail pharmacies, and primary healthcare institution. At the same time, Distribution of the Company transformed and upgraded to be the leading provider of pharmaceutical supply chain solutions. We integrate the supply chain and the Internet to achieve innovation in health related industries such as medicine and health care, and explore the collaborative development of diversified businesses. In the pharmaceutical retail field, Sinopharm Holding Guoda Drugstores Co., Ltd. is a pharmaceutical retail enterprise that ranks the first in the sales volume throughout the country, and is one of the few enterprises in China with national direct sales drug retail network. Up to the date of disclosure, Guoda Pharmacy has established Regional chains over 18 provinces, autonomous regions and municipalities.In recent years, Guoda pharmacy has been developing in conformity with the social development, continuously improving the professional level, and developing the management service of diabetes and hypertension. Insist on service innovation; establish retail diagnosis innovation stores covering all kinds of pharmaceutical resources, including traditional Chinese medicine, western medicine and rehabilitation therapy. We aim to build a reliable Chinese pharmaceutical and healthcare retail brand.

44 announcements tracked· Last: July 24, 2026

Key Financials

Revenue¥17.82bn
Net Profit¥287.5M
ROE1.52%
Debt Ratio55.39%
Monetary Funds¥5.18bn
Receivables¥23.90bn
Goodwill¥1.60bn
Total Shares533.7M

Announcements

44 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.